ArticleNeoplasia (New York, N.Y.)2010

Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation.

Winan J van Houdt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.